191 related articles for article (PubMed ID: 31758685)
1. Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.
Cruz-Lebrón A; D'argenio Garcia L; Talla A; Joussef-Piña S; Quiñones-Mateu ME; Sékaly RP; de Carvalho KIL; Levine AD
J Crohns Colitis; 2020 Jul; 14(6):791-800. PubMed ID: 31758685
[TBL] [Abstract][Full Text] [Related]
2. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
[TBL] [Abstract][Full Text] [Related]
3. Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
Eun CS; Kwak MJ; Han DS; Lee AR; Park DI; Yang SK; Kim YS; Kim JF
BMC Gastroenterol; 2016 Feb; 16():28. PubMed ID: 26922889
[TBL] [Abstract][Full Text] [Related]
4. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
9. A microbial signature for Crohn's disease.
Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.
Laserna-Mendieta EJ; Clooney AG; Carretero-Gomez JF; Moran C; Sheehan D; Nolan JA; Hill C; Gahan CGM; Joyce SA; Shanahan F; Claesson MJ
J Crohns Colitis; 2018 Jan; 12(2):204-216. PubMed ID: 29373727
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
[TBL] [Abstract][Full Text] [Related]
12. Association of Adherent-invasive
Zhilu X; Xiangqian D; Keli Y; Caroline C; Jingwan Z; Yu L; Tao Z; Cheung CL; Yang S; Fengrui Z; Kl CF; Jy SJ; Jun Y; Anthony B; Nicolas B; Jean-Frédéric C; Sunny Hei W; Yinglei M; Siew C N
Gut Microbes; 2021; 13(1):1994833. PubMed ID: 34812117
[TBL] [Abstract][Full Text] [Related]
13. Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.
Elzayat H; Malik T; Al-Awadhi H; Taha M; Elghazali G; Al-Marzooq F
Sci Rep; 2023 Nov; 13(1):19198. PubMed ID: 37932491
[TBL] [Abstract][Full Text] [Related]
14. A Distinct Gut Microbiota Exists Within Crohn's Disease-Related Perianal Fistulae.
Haac BE; Palmateer NC; Seaton ME; VanYPeren R; Fraser CM; Bafford AC
J Surg Res; 2019 Oct; 242():118-128. PubMed ID: 31075656
[TBL] [Abstract][Full Text] [Related]
15. A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
Zhang Z; Taylor L; Shommu N; Ghosh S; Reimer R; Panaccione R; Kaur S; Hyun JE; Cai C; Deehan EC; Hotte N; Madsen KL; Raman M
J Crohns Colitis; 2020 Nov; 14(11):1547-1557. PubMed ID: 32343765
[TBL] [Abstract][Full Text] [Related]
16. Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
von Martels JZH; Bourgonje AR; Klaassen MAY; Alkhalifah HAA; Sadaghian Sadabad M; Vich Vila A; Gacesa R; Gabriëls RY; Steinert RE; Jansen BH; Bulthuis MLC; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; de Vos P; van Goor H; Faber KN; Harmsen HJM; Dijkstra G
J Crohns Colitis; 2020 Jun; 14(5):595-607. PubMed ID: 31873717
[TBL] [Abstract][Full Text] [Related]
17. The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred.
Ijaz UZ; Quince C; Hanske L; Loman N; Calus ST; Bertz M; Edwards CA; Gaya DR; Hansen R; McGrogan P; Russell RK; Gerasimidis K
PLoS One; 2017; 12(2):e0172605. PubMed ID: 28222161
[TBL] [Abstract][Full Text] [Related]
18. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
19. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of changes in intestinal microbiota in Crohn's disease patients after anti-TNF alpha treatment.
Sanchis-Artero L; Martínez-Blanch JF; Manresa-Vera S; Cortés-Castell E; Valls-Gandia M; Iborra M; Paredes-Arquiola JM; Boscá-Watts M; Huguet JM; Gil-Borrás R; Rodríguez-Morales J; Cortés-Rizo X
Sci Rep; 2021 May; 11(1):10016. PubMed ID: 33976272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
